Health Care REIT (HCN)
Q2 2012 Earnings Call
August 06, 2012 10:00 am ET
Jeffrey H. Miller - Executive Vice President of Operations and General Counsel
George L. Chapman - Chairman, Chief Executive Officer, President, Member of Planning Committee, Member of Executive Committee and Member of Investment Committee
Scott A. Estes - Chief Financial Officer and Executive Vice President
Scott M. Brinker - Executive Vice President of Investments
Charles J. Herman - Chief Investment Officer and Executive Vice President
Wilfredo Guilloty - Morgan Stanley, Research Division
James Milam - Sandler O'Neill + Partners, L.P., Research Division
Jeff Theiler - Green Street Advisors, Inc., Research Division
Nicholas Yulico - Macquarie Research
Philip J. Martin - Morningstar Inc., Research Division
Michael W. Mueller - JP Morgan Chase & Co, Research Division
Todd Stender - Wells Fargo Securities, LLC, Research Division
James W. Sullivan - Cowen and Company, LLC, Research Division
Robert M. Mains - Stifel, Nicolaus & Co., Inc., Research Division
Jana Galan - BofA Merrill Lynch, Research Division
Karin A. Ford - KeyBanc Capital Markets Inc., Research Division
Good morning, ladies and gentlemen, and welcome to the Second Quarter 2012 Health Care REIT Earnings Conference Call. My name is Brooke, and I'll be your operator today. [Operator Instructions] As a reminder, this conference is being recorded for replay purposes. Now I would like to turn the call over to Jeff Miller, Executive Vice President, Operations and General Counsel. Please go ahead, sir.
Jeffrey H. Miller
Thank you, Brooke. Good morning, everyone, and thank you for joining us today for Health Care REIT's Second Quarter 2012 Conference Call. If you did not receive a copy of the news release distributed this morning, you may access it via the company's website at hcreit.com. We are holding a live webcast of today's call, which may be accessed through the company's website as well.
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts